Top insurtech funding rounds, April 2026

There were about 50 funding events in the insurtech sector in April 2026, according to a review by Digital Insurance. What follows is a selection of these. (Other funding events, such as private-equity infusions, are included in the overall count.)

A portion of the data was sourced from Crunchbase. Other information, including quotes from investing VCs, comes from company announcements. For our previous edition, which covered March, click here. These updates will continue monthly.

Openly

- Type of company: tech-enabled homeowners insurance provider
- Investors: Eden Global Partners, Advance Venture Partners, Gradient, Allianz X

"Openly is revolutionizing homeowners insurance with a disciplined, scalable underwriting model that emphasizes rigorous risk selection, precise pricing, and consistent portfolio management—yielding strong loss ratio results despite high natural catastrophe activity in the US in recent years," said Niklas Mundorf, senior manager at Allianz X North America, in a press release. "In a challenging market, Openly exemplifies how growth and responsibility can coexist, which is why we are deepening our commitment to elevate Openly and better serve this key market segment."

Tava Health

- Funding: $40 million Series C 
- Type of company: behavioral health platform
- Investors: Centana Growth Partners, Catalyst Investors, Blue Heron Ventures, Peterson Ventures, Springtide Ventures

"Tava Health is setting the new standard for mental healthcare infrastructure, delivery, and support," said Sarah Kim, partner at Centana Growth Partners, in a press release. "While healthtech continues to benefit from technology and AI, Tava Health's ability to solve administrative friction for providers while simultaneously removing the cost barrier for employers positions them as one of the most compelling mental health platforms in the market today."

Flora Fertility

- Funding: $5 million seed 
- Type of company: the first individually-owned fertility insurance platform
- Investors: ManchesterStory, Slauson & Co., TruStage Ventures, BDC Capital, Marathon Fund, Adara Venture Capital

"Flora is building something that has never existed before — affordable, portable fertility insurance that meets the next generation of women exactly where they are," said Nicole Gunderson, partner at ManchesterStory, in a press release. 

Amperos Health

-Funding: $16 million Series A
-Type of company: healthcare's first AI-native denial management and revenue recovery solution designed specifically for healthcare providers to combat denials and streamline claims collections for revenue cycle management (RCM) teams
-Investors: Bessemer Venture Partners, Uncork Capital, Neo

"Denials are one of healthcare's fastest-growing pain points: a growing portion of claims denied, hundreds of billions in lost revenue, and RCM teams that are chronically understaffed. It's a broken process ripe for AI transformation," said Sofia Guerra, partner at Bessemer Venture Partners, in a press release. "What sets Amperos apart is that they're the first truly agentic AI platform we've seen to automate this workflow end-to-end, from portal follow-ups and calls to corrected claims and appeals, with no handoffs and no gaps."

This roundup was created with AI assistance. A Digital Insurance editor reviewed each item before publication.